Teva Pharmaceutical Industries (TEVA) Preferred Shares (2015 - 2018)

Teva Pharmaceutical Industries (TEVA) has reported Preferred Shares for 4 consecutive years, with $3.8 billion the latest figure, recorded in Q3 2018.

• Quarterly Preferred Shares rose 5.66% year-over-year to $3.8 billion in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $3.8 billion (up 5.66% YoY) and the FY2017 annual result came in at $3.6 billion, changed 0.3% from the prior year.
• Preferred Shares climbed to $3.8 billion in Q3 2018 per TEVA's latest filing, from $3.8 billion in the prior quarter.
• Over the last five years, Preferred Shares for TEVA reached as high as $3.8 billion in Q3 2018 and fell as low as $3.3 billion in Q4 2015.
• A 4-year average of $3.6 billion and a median of $3.6 billion in 2016 frame the typical range for Preferred Shares.
• Annual changes were most pronounced in 2016 — Preferred Shares climbed 10.0% — and 2017, when it changed 0.0%.
• Year by year, Preferred Shares stood at $3.3 billion in 2015, then climbed by 10.0% to $3.6 billion in 2016, then increased by 0.3% to $3.6 billion in 2017, then advanced by 5.34% to $3.8 billion in 2018.
• According to Business Quant data, Preferred Shares over the past three periods registered $3.8 billion, $3.8 billion, and $3.7 billion for Q3 2018, Q2 2018, and Q1 2018 respectively.